Skip to main content
Top
Published in: World Journal of Urology 3/2007

01-06-2007 | Original Article

Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis

Authors: O. Karagülle, U. Smorag, F. Candir, G. Gundermann, U. Jonas, A. J. Becker, A. Gehrke, C. Gutenbrunner

Published in: World Journal of Urology | Issue 3/2007

Login to get access

Abstract

Investigations in healthy persons have shown that drinking mineral water containing HCO3 has a positive effect on urine supersaturated with calcium oxalate (SSCaOx). The present study evaluates in a common setting whether these effects are also relevant in patients with multiepisodic urinary stone formation. A total of 34 patients with evident multiepisodic CaOx-urolithiasis were included in the study. Patients with hyperparathyroidism, renal tubular acidosis, Wilson’s disease, Cushing disease, osteoporosis and malignant diseases were excluded. In a cross-over design and double-blinded the patients received 1.5 l of a mineral water with 2.673 mg HCO3/l (test water) or the same amount of water with a low mineral content (98 mg HCO3/l) (control water) daily for 3 days. During the study period the patients diet was recorded in a protocol, but not standardised. The main target parameter was SSCaOx in 24 h urine. In addition, urinary pH and the most important inhibiting and promoting factors were measured in 24 h urine (Ca, Ox, Mg, Cit). Both waters tested led to a highly significant increase in 24 h urine volume without a difference between each other. In the group, drinking the water containing HCO3 the urinary pH increased significantly and was within a range relevant for metaphylaxis of calcium oxalate stone formation (x = 6.73). This change was highly significant compared to the control group. In addition, significantly increased magnesium and citrate concentration were also observed. Supersaturation with calcium oxalate decreased significantly and to a relevant extent; however, there was no difference between the waters tested. As expected, the risk of uric acid precipitation also decreased significantly under bicarbonate water intake. However, an increase of the risk of calcium phosphate stone formation was observed. It is evident that both waters tested are able to lower significantly and to a relevant extent the risk of urinary stone formation in patients with multiepisodic CaOx-urolithiasis. In addition, the bicarbonate water increases the inhibitory factors citrate and magnesium due to its content of HCO3 and Mg. Thus, it can be recommended for metaphylaxis of calcium oxalate and uric acid urinary stones.
Literature
1.
go back to reference Achilles W, Ulshöfer B (1985) Calculation of complex chemical equilibria in urine: estimation of the risk of stone formation and derivation of prophylactic measures. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum, New York pp 777–780 Achilles W, Ulshöfer B (1985) Calculation of complex chemical equilibria in urine: estimation of the risk of stone formation and derivation of prophylactic measures. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W (eds) Urolithiasis and related clinical research. Plenum, New York pp 777–780
2.
go back to reference Ackermann D (1997) Empfehlungen zur Harnsteinmetaphylaxe-Kurzfassung für die tägliche Praxis. Urologe A 36:231–232PubMedCrossRef Ackermann D (1997) Empfehlungen zur Harnsteinmetaphylaxe-Kurzfassung für die tägliche Praxis. Urologe A 36:231–232PubMedCrossRef
3.
go back to reference Anderson RA (2002) A complementary approach to urolithiasis prevention. World J Urol 20:294–301PubMed Anderson RA (2002) A complementary approach to urolithiasis prevention. World J Urol 20:294–301PubMed
4.
go back to reference Böhmer I, Hesse A, Vahlensieck W (1985) Welchen Einfluss hat der Kalzium-Magnesium- und Natrium-Gehalt von Mineralwässern auf die Harnzusammensetzung? In: Gasser G, Vahlensieck W (eds). Pathogenese und Klinik der Harnsteine XI. Steinkopff, Darmstadt pp 160–173 Böhmer I, Hesse A, Vahlensieck W (1985) Welchen Einfluss hat der Kalzium-Magnesium- und Natrium-Gehalt von Mineralwässern auf die Harnzusammensetzung? In: Gasser G, Vahlensieck W (eds). Pathogenese und Klinik der Harnsteine XI. Steinkopff, Darmstadt pp 160–173
5.
go back to reference Butz M (1982) Oxalatsteinprophylaxe durch Alkali-Therapie. Urologe A 21:142–146PubMed Butz M (1982) Oxalatsteinprophylaxe durch Alkali-Therapie. Urologe A 21:142–146PubMed
6.
go back to reference Butz M (1989) Zitrat und Kalziumurolithiasis. Perimed-Fachbuch-Verlagsgesellschaft GmbH, Erlangen Butz M (1989) Zitrat und Kalziumurolithiasis. Perimed-Fachbuch-Verlagsgesellschaft GmbH, Erlangen
7.
go back to reference Caudarella R, Rizzoli E, Buffa A, Bottura A, Steffoni S (1998) Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 159:658–663PubMedCrossRef Caudarella R, Rizzoli E, Buffa A, Bottura A, Steffoni S (1998) Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. J Urol 159:658–663PubMedCrossRef
8.
go back to reference Finlayson B (1977) Calcium stones: same physical and clinical aspectes. In: David DS (ed) Calcium metabolism in renal failure and nephrolithiasis. Wiley, New York pp 337–382 Finlayson B (1977) Calcium stones: same physical and clinical aspectes. In: David DS (ed) Calcium metabolism in renal failure and nephrolithiasis. Wiley, New York pp 337–382
9.
go back to reference Ganter K, Winter P, Brockhaus S, Hesse A (1996) Alkalisierung des Harns zur Metaphylaxe bei Kalziumoxalatsteinleiden K-Zitrat vs. Na-K-Zitrat. Urologe B 36:461–465CrossRef Ganter K, Winter P, Brockhaus S, Hesse A (1996) Alkalisierung des Harns zur Metaphylaxe bei Kalziumoxalatsteinleiden K-Zitrat vs. Na-K-Zitrat. Urologe B 36:461–465CrossRef
10.
go back to reference Gilsdorf K, Gutenbrunner Chr (1987) Untersuchungen über den Einfluss calciumhaltiger Mineralwässer auf die Übersättigung des Harnes an Calciumoxalat. Z Phys Med 16:318–319 Gilsdorf K, Gutenbrunner Chr (1987) Untersuchungen über den Einfluss calciumhaltiger Mineralwässer auf die Übersättigung des Harnes an Calciumoxalat. Z Phys Med 16:318–319
11.
go back to reference Grizzle JE (1965) The two-period change-over design and its use in clinical trials. Biometrics 21:467–480PubMedCrossRef Grizzle JE (1965) The two-period change-over design and its use in clinical trials. Biometrics 21:467–480PubMedCrossRef
12.
go back to reference Gundermann G, Hoffmann H, Gutenbrunner Chr (2004) Trinken—aber was? Heilwässer in der Harnsteinmetaphylaxe. Ernähr Med 19:178–183CrossRef Gundermann G, Hoffmann H, Gutenbrunner Chr (2004) Trinken—aber was? Heilwässer in der Harnsteinmetaphylaxe. Ernähr Med 19:178–183CrossRef
13.
go back to reference Gutenbrunner Chr (1984) Zur Methodik der Prüfung von Wirkung und Wirksamkeit der Heilwasser-Trinkkuren. Ärztez Naturheilverfahr Regulationsmed 25:16–32 Gutenbrunner Chr (1984) Zur Methodik der Prüfung von Wirkung und Wirksamkeit der Heilwasser-Trinkkuren. Ärztez Naturheilverfahr Regulationsmed 25:16–32
14.
go back to reference Gutenbrunner Chr (1988) Die Bedeutung von Trinkkuren bei der Harnsteinmetaphylaxe. Therapiewoche 38:1605–1615 Gutenbrunner Chr (1988) Die Bedeutung von Trinkkuren bei der Harnsteinmetaphylaxe. Therapiewoche 38:1605–1615
15.
go back to reference Gutenbrunner Chr, Gilsdorf K, Hildebrandt G (1989) Untersuchungen über den Einfluß kalziumhaltiger Mineralwässer auf die Übersättigung des Harnes mit Kalziumoxalat. Urologe A 28:15–19 Gutenbrunner Chr, Gilsdorf K, Hildebrandt G (1989) Untersuchungen über den Einfluß kalziumhaltiger Mineralwässer auf die Übersättigung des Harnes mit Kalziumoxalat. Urologe A 28:15–19
16.
go back to reference Gutenbrunner Chr, Hildebrandt G (1994) Handbuch der Heilwasser-Trinkkuren: Theorie und Praxis. Johannes Sonntag Verlagsbuchhandlung GmbH, Stuttgart Gutenbrunner Chr, Hildebrandt G (1994) Handbuch der Heilwasser-Trinkkuren: Theorie und Praxis. Johannes Sonntag Verlagsbuchhandlung GmbH, Stuttgart
17.
go back to reference Gutenbrunner Chr, Hildebrandt G (1998) Handbuch der Balneologie und medizinischen Klimatologie. Springer, Berlin Gutenbrunner Chr, Hildebrandt G (1998) Handbuch der Balneologie und medizinischen Klimatologie. Springer, Berlin
18.
go back to reference Hecker H (1986) Identification and interpretation of effects in two-period cross-over designs. EDV Med Biol 17:60–66 Hecker H (1986) Identification and interpretation of effects in two-period cross-over designs. EDV Med Biol 17:60–66
19.
go back to reference Hess B (2003) Pathophysiologie, Diagnostik und konservative Therapie bei Kalzium-Nierensteinen. Ther Umsch 60:79–87PubMedCrossRef Hess B (2003) Pathophysiologie, Diagnostik und konservative Therapie bei Kalzium-Nierensteinen. Ther Umsch 60:79–87PubMedCrossRef
20.
go back to reference Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44:709–713PubMedCrossRef Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44:709–713PubMedCrossRef
21.
go back to reference Hesse A, Jahnen A, Klocke K, Nolde A, Scharrel O (1994) Nachsorge bei Harnstein-Patienten. Ein Leitfaden für die ärztliche Praxis. Gustav Fischer Verlag, Jena Hesse A, Jahnen A, Klocke K, Nolde A, Scharrel O (1994) Nachsorge bei Harnstein-Patienten. Ein Leitfaden für die ärztliche Praxis. Gustav Fischer Verlag, Jena
22.
go back to reference Hesse A, Jöge S, Jahnen A, Schmitz W, Klocke K (1993) Anwendung von Natriumhydrogenkarbonat zur Alkalisierungstherapie bei Kalziumoxalatsteinpatienten. Urologe B 33:160–163 Hesse A, Jöge S, Jahnen A, Schmitz W, Klocke K (1993) Anwendung von Natriumhydrogenkarbonat zur Alkalisierungstherapie bei Kalziumoxalatsteinpatienten. Urologe B 33:160–163
23.
go back to reference Hesse A, Siener R (1997) Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 15:165–171PubMedCrossRef Hesse A, Siener R (1997) Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 15:165–171PubMedCrossRef
24.
go back to reference Hesse A, Tiselius HG, Jahnen A (2002) Urinary stones: diagnosis, treatment and prevention of recurrence 2nd edn. Karger, Basel Hesse A, Tiselius HG, Jahnen A (2002) Urinary stones: diagnosis, treatment and prevention of recurrence 2nd edn. Karger, Basel
25.
go back to reference Hills M, Armitage P (1979) The two-period cross-over clinical trial. Br J Clin Pharmacol 8:7–20PubMed Hills M, Armitage P (1979) The two-period cross-over clinical trial. Br J Clin Pharmacol 8:7–20PubMed
26.
go back to reference Karagülle O, Kleczka T, Vidal C, Candir F, Gundermann G, Külpmann WR, Gehrke A, Gutenbrunner C (2006) Magnesium absorption from mineral waters of different magnesium content in healthy subjects. Forsch Komplementärmed 13:9–14PubMedCrossRef Karagülle O, Kleczka T, Vidal C, Candir F, Gundermann G, Külpmann WR, Gehrke A, Gutenbrunner C (2006) Magnesium absorption from mineral waters of different magnesium content in healthy subjects. Forsch Komplementärmed 13:9–14PubMedCrossRef
27.
go back to reference Kessler T, Hesse A (1998) Harnsäure-und Kalziumoxalatsteinmetaphylaxe mit natriumbikarbonathaltigem Heilwasser. Urologe B 38:363–369CrossRef Kessler T, Hesse A (1998) Harnsäure-und Kalziumoxalatsteinmetaphylaxe mit natriumbikarbonathaltigem Heilwasser. Urologe B 38:363–369CrossRef
28.
go back to reference Kessler T, Hesse A (2000) Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects. Br J Nutr 84:856–871 Kessler T, Hesse A (2000) Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects. Br J Nutr 84:856–871
29.
go back to reference Lee YH, Huang WC, Tsai JY, Huang JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161:1453–1457PubMedCrossRef Lee YH, Huang WC, Tsai JY, Huang JK (1999) The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: a midterm follow-up study. J Urol 161:1453–1457PubMedCrossRef
30.
go back to reference Leumann E, Hoppe B, Neuhaus T, Blau N (1995) Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 10(Suppl 8):14–16PubMed Leumann E, Hoppe B, Neuhaus T, Blau N (1995) Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 10(Suppl 8):14–16PubMed
31.
go back to reference Lux B, Braun J, May P (1982) Purinbelastungstest bei Calcium-Oxalat-Steinbildnern. Urologe A 21:147–149PubMed Lux B, Braun J, May P (1982) Purinbelastungstest bei Calcium-Oxalat-Steinbildnern. Urologe A 21:147–149PubMed
32.
go back to reference Marangella M, Vitale C, Petrarulo M, Rovera L, Dutto F (1996) Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis. Clin Sci 91:313–318PubMed Marangella M, Vitale C, Petrarulo M, Rovera L, Dutto F (1996) Effects of mineral composition of drinking water on risk for stone formation and bone metabolism in idiopathic calcium nephrolithiasis. Clin Sci 91:313–318PubMed
33.
go back to reference Müller SC, Hofmann R, Köhrmann KU, Hesse A (2004) Epidemiologie, instrumentelle Therapie und Metaphylaxe des Harnsteinleidens. Dtsch Ärztebl Jg101.19:1101–1106 Müller SC, Hofmann R, Köhrmann KU, Hesse A (2004) Epidemiologie, instrumentelle Therapie und Metaphylaxe des Harnsteinleidens. Dtsch Ärztebl Jg101.19:1101–1106
34.
go back to reference Pak CY, Poindexer JR, Peterson RD, Koska J, Sakhaee K (2002) Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 60:789–794PubMedCrossRef Pak CY, Poindexer JR, Peterson RD, Koska J, Sakhaee K (2002) Biochemical distinction between hyperuricosuric calcium urolithiasis and gouty diathesis. Urology 60:789–794PubMedCrossRef
35.
go back to reference Reinecke F, Maack J (1981) Die Prophylaxe der rezidivierenden Oxalatsteine mit Allopurinol. Therapiewoche 31:1325–1326 Reinecke F, Maack J (1981) Die Prophylaxe der rezidivierenden Oxalatsteine mit Allopurinol. Therapiewoche 31:1325–1326
36.
go back to reference Rodgers AL (1997) Effect of mineral water containinig calcium and magnesium on calcium oxalate urolithiasis risk factors. Urol Int 58:93–99PubMedCrossRef Rodgers AL (1997) Effect of mineral water containinig calcium and magnesium on calcium oxalate urolithiasis risk factors. Urol Int 58:93–99PubMedCrossRef
37.
go back to reference Sakhaee K, Nicar M, Hill K, Pak CY (1983) Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and cristallization of stone forming salts. Kidney Int 24:348–352PubMed Sakhaee K, Nicar M, Hill K, Pak CY (1983) Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and cristallization of stone forming salts. Kidney Int 24:348–352PubMed
39.
go back to reference Siener R, Jahnen A, Hesse A (2004) Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 58:270–276PubMedCrossRef Siener R, Jahnen A, Hesse A (2004) Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization. Eur J Clin Nutr 58:270–276PubMedCrossRef
40.
go back to reference Smorag U, Karagülle O, Gundermann G, Becker AJ, Jonas U, Gehrke A, Gutenbrunner Chr (2005) Sind Heilwässer in der Metaphylaxe der Urolithiasis auch bei Patienten mit Hyperkalziurie oder Hyperoxalurie geeignet? Phys Med Rehab Kuror 15:262 Smorag U, Karagülle O, Gundermann G, Becker AJ, Jonas U, Gehrke A, Gutenbrunner Chr (2005) Sind Heilwässer in der Metaphylaxe der Urolithiasis auch bei Patienten mit Hyperkalziurie oder Hyperoxalurie geeignet? Phys Med Rehab Kuror 15:262
41.
go back to reference Strohmaier WL (2000) Volkswirtschaftliche Aspekte des Harnsteinleidens und der Harnsteinmetaphylaxe. Urologe A 39:166–170PubMedCrossRef Strohmaier WL (2000) Volkswirtschaftliche Aspekte des Harnsteinleidens und der Harnsteinmetaphylaxe. Urologe A 39:166–170PubMedCrossRef
42.
43.
go back to reference Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Galluci M (2001) Guidelines on Urolithiasis. Eur Urol 40:362–371PubMedCrossRef Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Galluci M (2001) Guidelines on Urolithiasis. Eur Urol 40:362–371PubMedCrossRef
44.
go back to reference Ulshöfer B, Naber K, Achilles W, Rohani AM (1985) Der Einfluß des Kalziumgehaltes verschiedener Wässer auf die Kalziumausscheidung und das Steinbildungsrisiko. In: Gasser G, Vahlensieck W (eds) Pathogenese und Klinik der Harnsteine XI. Steinkopff, Darmstadt pp 174–179 Ulshöfer B, Naber K, Achilles W, Rohani AM (1985) Der Einfluß des Kalziumgehaltes verschiedener Wässer auf die Kalziumausscheidung und das Steinbildungsrisiko. In: Gasser G, Vahlensieck W (eds) Pathogenese und Klinik der Harnsteine XI. Steinkopff, Darmstadt pp 174–179
45.
go back to reference Wagenknecht LV, Lotzin CF, Napp R, Freerksen E (1981) Steinprophylaktische Elektrobalance unter stationären Bedingungen. Therapiewoche 31:1314–1318 Wagenknecht LV, Lotzin CF, Napp R, Freerksen E (1981) Steinprophylaktische Elektrobalance unter stationären Bedingungen. Therapiewoche 31:1314–1318
46.
go back to reference Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 143:1242–1244 Werness PG, Brown CM, Smith LH, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 143:1242–1244
47.
go back to reference www.bundesaerztekammer.de/30/versorgungsforschung/10Definition/ www.bundesaerztekammer.de/30/versorgungsforschung/10Definition/
Metadata
Title
Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis
Authors
O. Karagülle
U. Smorag
F. Candir
G. Gundermann
U. Jonas
A. J. Becker
A. Gehrke
C. Gutenbrunner
Publication date
01-06-2007
Publisher
Springer-Verlag
Published in
World Journal of Urology / Issue 3/2007
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-007-0144-0

Other articles of this Issue 3/2007

World Journal of Urology 3/2007 Go to the issue